Please wait a minute...
Clinical and Experimental Obstetrics & Gynecology  2014, Vol. 41 Issue (1): 83-86    DOI: 10.12891/ceog16202014
Case Report Previous articles | Next articles
Recurrent peritoneal inclusion cysts successfully treated with oral contraceptives: a report of two cases
N. Yokoyama1, *(), R. Yasuda1, K. Ichida1, H. Murakoshi1, J. Okada1, S. Yoshida1, S. Motoyama1
1Department of Obstetrics and Gynecology, Chibune General Hospital, Osaka (Japan)
Download:  PDF(166KB)  ( 5 )
Export:  BibTeX | EndNote (RIS)      
Abstract  
Objective: To examine whether conservative treatment with oral contraceptives is effective in the shrinkage of a peritoneal inclusion cyst (PIC). This is a case report of two patients with a PIC that developed after gynecological surgery. Cases: Both cases were suspected of a PIC based on the medical history, laboratory data, and image findings. It was difficult in differentiate a PIC from an ovarian tumor. Surgery was chosen at first. However, PICs in both cases recurred after surgery and were treated with oral contraceptives as a conservative treatment. PICs shrank after the treatment of oral contraceptives in both cases. Conclusion: Due to the high rate of recurrence following surgery, conservative treatment is recommended to treat PICs. Hormone therapy using oral contraceptives seems to have some therapeutic benefit for the PICs.
Key words:  Peritoneal inclusion cyst      Oral contraceptives      Conservative treatment      Sclerotherapy      Vibramycin     
Published:  10 February 2014     
*Corresponding Author(s):  N. YOKOYAMA     E-mail:  nobukun107@hotmail.com

Cite this article: 

N. Yokoyama, R. Yasuda, K. Ichida, H. Murakoshi, J. Okada, S. Yoshida, S. Motoyama. Recurrent peritoneal inclusion cysts successfully treated with oral contraceptives: a report of two cases. Clinical and Experimental Obstetrics & Gynecology, 2014, 41(1): 83-86.

URL: 

https://ceog.imrpress.com/EN/10.12891/ceog16202014     OR     https://ceog.imrpress.com/EN/Y2014/V41/I1/83

[1] J. Jin, J. Tang. Clinical application and economics of five short-acting combined oral contraceptives over five years of obstetrics and gynecology practice in China based on real-world study[J]. Clinical and Experimental Obstetrics & Gynecology, 2020, 47(6): 940-949.
[2] N.B. Mulchandani, J.J. Jauregui, R. Abraham, E. Seger, E. Illical. Post-partum management of severe pubic diastasis[J]. Clinical and Experimental Obstetrics & Gynecology, 2017, 44(3): 464-466.
[3] Y. X. Zhang. Effect of mifepristone in the different treatments of endometriosis[J]. Clinical and Experimental Obstetrics & Gynecology, 2016, 43(3): 350-353.
[4] G. Di Luigi, F. Patacchiola, L. Di Stefano, A. D’Alfonso, A. Carta, G. Carta. Placenta accreta: conservative approach[J]. Clinical and Experimental Obstetrics & Gynecology, 2013, 40(4): 596-598.
[5] S. Bulur, M. Albayrak, Ş. Bulur, F. Keskin, S.A. Köse, Y. Aslantaş, Y. Türker, H. Özhan. Effect of combined oral contraceptive use on platelet volume in women at reproductive age[J]. Clinical and Experimental Obstetrics & Gynecology, 2012, 39(3): 314-316.
[6] G. Iatrakis, C. Iavazzo, S. Zervoudis, A. Koumousidis, C. Sofoudis, T. Kalampokas, N. Salakos. The role of oral contraception use in the occurrence of breast cancer. A retrospective study of 405 patients[J]. Clinical and Experimental Obstetrics & Gynecology, 2011, 38(3): 225-227.
[7] M. Küçük, S.D. Sezer, A.R. Odabaşi, Z. Güner, H. Yuksel, M. Serter. The effect of low-dose combined oral contraceptive containing 100 ug levonorgestrel on plasma plasminogen activator inhibitor-1 concentrations[J]. Clinical and Experimental Obstetrics & Gynecology, 2011, 38(1): 54-56.
[8] S. Ayas, I. Akoz, A. Karateke, O. Bozoklu. Successful medical treatment of cesarean scar pregnancy: a case report[J]. Clinical and Experimental Obstetrics & Gynecology, 2007, 34(3): 195-196.
[9] K. Stamatiou, G. Petrakos, A. Alevizos, K. Bovis, A. Economou, P. Panagopoulos, A. Mariolis. Endometriosis of ureter-induced recurrent urinary tract infections in a premenopausal woman - case report[J]. Clinical and Experimental Obstetrics & Gynecology, 2007, 34(1): 63-64.
[10] M. L. Framarino Dei Malatesta, M. Veneziano, M. G. Piccioni, F. Pecorini, A. Gaveglia, A. Felici, L. Marzetti. Ovarian cysts in the postmenopause: is a conservative treatment feasible?[J]. Clinical and Experimental Obstetrics & Gynecology, 1993, 20(3): 151-158.
[11] A. Granata, G. A. Sobbrio, F. D’Arrigo, M. Barillari, P. De Luca, M. Egitto, D. Granese, C. Pulle, F. Trimarchi. Changes in the plasm.a levels of proteins C and S in young women on low-dose oestrogen oral contraceptives[J]. Clinical and Experimental Obstetrics & Gynecology, 1991, 18(1): 9-12.
[12] F. Pansini, C. Ferrari, S. Guerra, P. Bassi, N. Guzzinati, G. Cocilovo, G. Mollica. Advantage of desogestrel containing pill in oral contraception: influence on blood lipids and lcat activity[J]. Clinical and Experimental Obstetrics & Gynecology, 1987, 14(3-4): 136-139.
No Suggested Reading articles found!